Cited by 807Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseViral Infections and Immunology Research

The DOI matches its Crossref record; 518 of the 518 references it cites were found in a registry or an index.

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Ommen, Steve R., Ho, Carolyn Y., Asif, Irfan M., Balaji, Seshadri, Burke, Michael A., Day, Sharlene M., Dearani, Joseph A., Epps, Kelly C., Evanovich, Lauren, Ferrari, Victor A., Joglar, José A., Khan, Sadiya S., Kim, Jeffrey J., Kittleson, Michelle M., Krittanawong, Chayakrit, Martinez, Matthew W., Mital, Seema, Naidu, Srihari S., Saberi, Sara, Semsarian, Christopher, Times, Sabrina, Waldman, Cynthia Burstein·2024·Circulation

DOI 10.1161/cir.0000000000001250

Open this paper in CoChat — free account

Abstract

AIM: The “2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy” provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy. METHODS: A comprehensive literature search was conducted from September 14, 2022, to November 22, 2022, encompassing studies, reviews, and other evidence on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through May 23, 2023, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate. STRUCTURE: Hypertrophic cardiomyopathy remains a common genetic heart disease reported in populations globally. Recommendations from the “2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy” have been updated with new evidence to guide clinicians.

Integrity signals

Registry

Crossref · 10.1161/cir.0000000000001250

Cites

518 of 518 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
The Physical Activity Guidelines for Americans
Piercy, K. L., Troiano, R. P., Ballard, R. M., Carlson, S. A., Fulton, J. E., Galuska, D. A., George, S. M., & Olson, R. D. (2018) · JAMA · doi:10.1001/jama.2018.14854 · Cited by 9,755
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
2011 Compendium of Physical Activities: A Second Update of Codes and MET Values
AINSWORTH, B. E., HASKELL, W. L., HERRMANN, S. D., MECKES, N., BASSETT, D. R., TUDOR-LOCKE, C., GREER, J. L., VEZINA, J., WHITT-GLOVER, M. C., & LEON, A. S. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31821ece12 · Cited by 6,317
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, J., Erdmann, E., Freemantle, N., Gras, D., KAPPENBERGER, L. J., & Tavazzi, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050496 · Cited by 6,300
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Self-citation
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,244
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., Estes, N. A. M., Foster, E., Greenberg, H., Higgins, S. L., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906431 · Cited by 3,157
Clinical Practice Guidelines We Can Trust
Board on Health Care Services (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,146
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A. M., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 3,072
Self-citation
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
January, C. T., Wann, L. S., Calkins, H., Chen, L. Y., Cigarroa, J. E., Cleveland, J. C., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., Furie, K. L., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000665 · Cited by 2,744
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437739.71477.ee · Cited by 2,735
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,234
Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update: A Guideline From the American Heart Association
Mosca, L., Benjamin, E. J., Berra, K., Bezanson, J. L., Dolor, R. J., Lloyd-Jones, D. M., Newby, L. K., Piña, I. L., Roger, V. L., Shaw, L. J., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820faaf8 · Cited by 2,143
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,116
Self-citation
Subclinical atrial fibrillation and the risk of stroke
Healey, J. S., Connolly, S. J., Gold, M. R., Israel, C. W., Van Gelder, I. C., Capucci, A., Lau, C. P., Fain, E., Yang, S., Bailleul, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105575 · Cited by 2,100
Sudden Deaths in Young Competitive Athletes
Maron, B. J., Doerer, J. J., Haas, T. S., Tierney, D. M., & Mueller, F. O. (2009) · Circulation · doi:10.1161/circulationaha.108.804617 · Cited by 2,099
Assessing the Effects of Physician-Patient Interactions on the Outcomes of Chronic Disease
Kaplan, S. H., Greenfield, S., & Ware, J. E. (1989) · Medical Care · doi:10.1097/00005650-198903001-00010 · Cited by 2,043
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3182051b4c · Cited by 1,976
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update: A Guideline From the American Heart Association and American College of Cardiology Foundation
Smith, S. C., Benjamin, E. J., Bonow, R. O., Braun, L. T., Creager, M. A., Franklin, B. A., Gibbons, R. J., Grundy, S. M., Hiratzka, L. F., Jones, D. W., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318235eb4d · Cited by 1,759
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
Epstein, A. E., Dimarco, J., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e318276ce9b · Cited by 1,496
Expanding Patient Involvement in Care
Greenfield, S., Kaplan, S. H., & Ware, J. E. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-4-520 · Cited by 1,459
The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update
Mehra, M. R., Canter, C. E., Hannan, M. M., Semigran, M. J., Uber, P. A., Baran, D. A., Danziger‐Isakov, L. A., Kirklin, J. K., Kirk, R., Kushwaha, S. S., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.10.023 · Cited by 1,424
New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy
Semsarian, C., Ingles, J., Maron, M. S., & Maron, B. J. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.019 · Cited by 1,405
Self-citation
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
Marian, A. J., & Braunwald, E. (2017) · Circulation Research · doi:10.1161/circresaha.117.311059 · Cited by 1,403
Does sports activity enhance the risk of sudden death in adolescents and young adults?
Corrado, D., Basso, C., Rizzoli, G., Schiavon, M., & Thiene, G. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.03.002 · Cited by 1,311
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
Olivotto, I., Oreziak, A., Barriales-Villa, R., Abraham, T. P., Masri, A., Garcia-Pavia, P., Saberi, S., Lakdawala, N. K., Wheeler, M. T., Owens, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31792-x · Cited by 1,296
Self-citation
Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy
Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)
O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht439 · Cited by 1,251
Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy
Spirito, P., Bellone, P., Harris, K. M., Bernabò, P., Bruzzi, P., & Maron, B. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422403 · Cited by 1,142
Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction
Maron, M. S., Olivotto, I., Zenovich, A. G., Link, M. S., Pandian, N. G., Kuvin, J. T., Nistri, S., Cecchi, F., Udelson, J. E., & Maron, B. J. (2006) · Circulation · doi:10.1161/circulationaha.106.644682 · Cited by 1,127
Patients’ participation in medical care
Greenfield, S., Kaplan, S. H., Ware, J. E., Yano, E. M., & Frank, H. J. L. (1988) · Journal of General Internal Medicine · doi:10.1007/bf02595921 · Cited by 1,117
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients
Elliot, P. M., Poloniecki, J. D., Dickie, S., Sharma, S., Monserrat, L., Varnava, A. M., Mahon, N., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 976
Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy
Chan, R. H., Maron, B. J., Olivotto, I., Pencina, M. J., Assenza, G. E., Haas, T., Lesser, J. R., Gruner, C., Crean, A. M., Rakowski, H., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.007094 · Cited by 962
Clinical Course and Management of Hypertrophic Cardiomyopathy
Maron, B. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1710575 · Cited by 944
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000435 · Cited by 906
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
Ho, C. Y., Day, S. M., Ashley, E. A., Michels, M., Pereira, A. C., Jacoby, D., Cirino, A. L., Fox, J. C., Lakdawala, N. K., Ware, J. S., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.033200 · Cited by 860
Self-citation
A Prospective Study of Sudden Cardiac Death among Children and Young Adults
Bagnall, R. D., Weintraub, R. G., Ingles, J., Duflou, J. A., Yeates, L., Lam, L., Davis, A. M., Thompson, T. N., Connell, V., Wallace, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1510687 · Cited by 847
Self-citation
Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy
Maron, B. J., Shen, W.-K., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Bardy, G. H., Favale, S., Rea, R. F., Boriani, G., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420601 · Cited by 832
Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review
Wigle, E. D., Sasson, Z., Henderson, M. A., Ruddy, T. D., Fulop, J. C., Rakowski, H., & Williams, W. G. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(85)90024-6 · Cited by 822
Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy
Ommen, S. R., Maron, B. J., Olivotto, I., Maron, M. S., Cecchi, F., Betocchi, S., Gersh, B. J., Ackerman, M. J., McCully, R. B., Dearani, J. A., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.090 · Cited by 812
Self-citation
Genetic Misdiagnoses and the Potential for Health Disparities
Manrai, A. K., Funke, B. H., Rehm, H. L., Olesen, M. S., Maron, B. A., Szolovits, P., Margulies, D. M., Loscalzo, J., & Kohane, I. S. (2016) · New England Journal of Medicine · doi:10.1056/nejmsa1507092 · Cited by 808
Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Maron, B. J., Spirito, P., Shen, W.-K., Haas, T. S., Formisano, F., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Lawrenz, T., et al. (2007) · JAMA · doi:10.1001/jama.298.4.405 · Cited by 802
Self-citation
Patient participation in decision-making
Guadagnoli, E., & Ward, P. (1998) · Social Science & Medicine · doi:10.1016/s0277-9536(98)00059-8 · Cited by 795
Comparison of β-Blockers, Amiodarone Plus β-Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter Defibrillators<SUBTITLE>The OPTIC Study: A Randomized Trial</SUBTITLE>
Connolly, S. J. (2006) · JAMA · doi:10.1001/jama.295.2.165 · Cited by 788
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000549 · Cited by 771
Self-citation
Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy
Maron, B. J., Wolfson, J. K., Epstein, S. E., & Roberts, W. C. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80181-4 · Cited by 754
Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy
Olivotto, I., Cecchi, F., Casey, S. A., Dolara, A., Traverse, J. H., & Maron, B. J. (2001) · Circulation · doi:10.1161/hc4601.097997 · Cited by 745
Pulsed Field Ablation for Pulmonary Vein Isolation in Atrial Fibrillation
Reddy, V. Y., Neužil, P., Koruth, J. S., Petrů, J., Funosako, M., Cochet, H., Šedivá, L., Chovanec, M., Dukkipati, S. R., & Jaı̈s, P. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.04.021 · Cited by 716
A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice
Green, E. M., Wakimoto, H., Anderson, R. L., Evanchik, M. J., Gorham, J., Harrison, B. C., Henze, M., Kawas, R. F., Oslob, J. D., Rodrı́guez, H. M., et al. (2016) · Science · doi:10.1126/science.aad3456 · Cited by 708
Genetics of Hypertrophic Cardiomyopathy After 20 Years
Maron, B. J., Maron, M. S., & Semsarian, C. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.068 · Cited by 702
Self-citation
Interventions for increasing the use of shared decision making by healthcare professionals
Légaré, F., Adekpedjou, R., Stacey, D., Turcotte, S., Kryworuchko, J., Graham, I. D., Lyddiatt, A., Politi, M. C., Thomson, R., Elwyn, G., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006732.pub4 · Cited by 698
ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography
Douglas, P. S., Garcia, M. J., Haines, D. E., Lai, W. W., Manning, W. J., Patel, A. R., Picard, M. H., Polk, D. M., Ragosta, M., Ward, R. P., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.002 · Cited by 681
Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy
Harris, K. M., Spirito, P., Maron, M. S., Zenovich, A. G., Formisano, F., Lesser, J. R., Mackey‐Bojack, S., Manning, W. J., Udelson, J. E., & Maron, B. J. (2006) · Circulation · doi:10.1161/circulationaha.105.583500 · Cited by 665
Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients
Klues, H. G., Schiffers, A., & Maron, B. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00390-8 · Cited by 653
Hypertrophic Cardiomyopathy
Maron, B. J., Ommen, S. R., Semsarian, C., Spirito, P., Olivotto, I., & Maron, M. S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.003 · Cited by 652
Self-citation
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
Ommen, S. R., Mital, S. R., Burke, M. A., Day, S. M., Deswal, A. M., Elliot, P. M., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P. F., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000937 · Cited by 641
Self-citation
Diagnosis and Evaluation of Hypertrophic Cardiomyopathy
Maron, B. J., Desai, M. Y., Nishimura, R. A., Spirito, P., Rakowski, H., Towbin, J. A., Rowin, E. J., Maron, M. S., & Sherrid, M. V. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.002 · Cited by 637
Incidence of Sudden Cardiac Death in National Collegiate Athletic Association Athletes
Harmon, K. G., Asif, I. M., Klossner, D. A., & Drezner, J. A. (2011) · Circulation · doi:10.1161/circulationaha.110.004622 · Cited by 623
Self-citation
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.011 · Cited by 617
Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT
Gelder, I. C. V., Healey, J. S., Crijns, H. J. G. M., Wang, J., Hohnloser, S. H., Gold, M. R., Capucci, A., Lau, C., Morillo, C. A., Hobbelt, A. H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx042 · Cited by 604
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Kusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000628 · Cited by 603
Self-citation
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000311 · Cited by 595
Self-citation
Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy
Rickers, C., Wilke, N. M., Jerosch‐Herold, M., Casey, S. A., Panse, P. M., Panse, N., Weil, J., Zenovich, A. G., & Maron, B. J. (2005) · Circulation · doi:10.1161/circulationaha.104.507723 · Cited by 581
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy
Monserrat, L., Elliott, P. M., Gimeno, J. R., Sharma, S., Penas-Lado, M., & McKenna, W. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00827-1 · Cited by 541
ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures
Anderson, J. L., Heidenreich, P. A., Barnett, P. G., Creager, M. A., Fonarow, G. C., Gibbons, R. J., Halperin, J. L., Hlatky, M. A., Jacobs, A. K., Mark, D. B., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000042 · Cited by 521
Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy
Elliot, P. M., Gimeno, J. R., Mahon, N., Poloniecki, J. D., & McKenna, W. J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04005-8 · Cited by 517
Hypertrophic Cardiomyopathy Phenotype Revisited After 50 Years With Cardiovascular Magnetic Resonance
Maron, M. S., Maron, B. J., Harrigan, C. J., Buros, J., Gibson, C. M., Olivotto, I., Biller, L. H., Lesser, J. R., Udelson, J. E., Manning, W. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.006 · Cited by 501
Ratings of Perceived Exertion and Heart Rates During Short-Term Cycle Exercise and Their Use in a New Cycling Strength Test*
Borg, G. (1982) · International Journal of Sports Medicine · doi:10.1055/s-2008-1026080 · Cited by 496
Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study
Maron, B. J., Savage, D. D., Wolfson, J. K., & Epstein, S. E. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90604-4 · Cited by 494
Assessment of Permanent Dual-Chamber Pacing as a Treatment for Drug-Refractory Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy
Maron, B. J., Nishimura, R. A., McKenna, W. J., Rakowski, H., Josephson, M. E., & Kieval, R. S. (1999) · Circulation · doi:10.1161/01.cir.99.22.2927 · Cited by 490
Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Charron, P., Arad, M., Arbustini, E., Basso, C., Bilińska, Z. T., Elliot, P. M., Heliö, T. M., Keren, A., McKenna, W. J., Monserrat, L., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq271 · Cited by 486
Prognostic Value of LGE-CMR in HCM
Weng, Z., Yao, J., Chan, R. H. M., He, J., Yang, X., Zhou, Y., & He, Y. (2016) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2016.02.031 · Cited by 482
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.
Cannon, R. O., Rosing, D. R., Maron, B. J., Leon, M. B., Bonow, R. O., Watson, R. M., & Epstein, S. E. (1985) · Circulation · doi:10.1161/01.cir.71.2.234 · Cited by 477
Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children
Colan, S. D., Lipshultz, S. E., Lowe, A. M., Sleeper, L. A., Messere, J. E., Cox, G. F., Lurie, P. R., Orav, E. J., & Towbin, J. A. (2007) · Circulation · doi:10.1161/circulationaha.106.621185 · Cited by 472
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis
Maron, B. J., Udelson, J. E., Bonow, R. O., Nishimura, R. A., Ackerman, M. J., Estes, N. A. M., Cooper, L. T., Link, M. S., & Maron, M. S. (2015) · Circulation · doi:10.1161/cir.0000000000000239 · Cited by 462
Mitral Valve Abnormalities Identified by Cardiovascular Magnetic Resonance Represent a Primary Phenotypic Expression of Hypertrophic Cardiomyopathy
Maron, M. S., Olivotto, I., Harrigan, C. J., Appelbaum, E. A., Gibson, C. M., Lesser, J. R., Haas, T. S., Udelson, J. E., Manning, W. J., & Maron, B. J. (2011) · Circulation · doi:10.1161/circulationaha.110.985812 · Cited by 448
Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography
Moon, J., Fisher, N. G., McKenna, W. J., & Pennell, D. J. (2004) · Heart · doi:10.1136/hrt.2003.014969 · Cited by 439
Gender-Related Differences in the Clinical Presentation and Outcome of Hypertrophic Cardiomyopathy
Olivotto, I., Maron, M. S., Adabağ, S., Casey, S. A., Vargiu, D., Link, M. S., Udelson, J. E., Cecchi, F., & Maron, B. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.043 · Cited by 436
Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes
Ingles, J., Goldstein, J., Thaxton, C., Caleshu, C. A., Corty, E. W., Crowley, S. B., Dougherty, K. E., Harrison, S. M., McGlaughon, J., Milko, L. V., et al. (2019) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.119.002460 · Cited by 434
Self-citation
Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update
Porter, T. R., Mulvagh, S. L., Abdelmoneim, S. S., Becher, H. H., Belcik, J. T., Bierig, M., Choy, J. B., Gaibazzi, N., Gillam, L. D., Janardhanan, R., et al. (2018) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2017.11.013 · Cited by 432
Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)
Boriani, G., Glotzer, T. V., Santini, M., West, T. M., De Melis, M., Sepsi, M., Gasparini, M., Lewalter, T., Camm, J. A., & Singer, D. E. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht491 · Cited by 427
Assessment of Diastolic Function With Doppler Tissue Imaging to Predict Genotype in Preclinical Hypertrophic Cardiomyopathy
Ho, C. Y., Sweitzer, N. K., McDonough, B. A., Maron, B. J., Casey, S. A., Seidman, J. G., Seidman, C. E., & Solomon, S. D. (2002) · Circulation · doi:10.1161/01.cir.0000019070.70491.6d · Cited by 420
Self-citation
Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy
Chaffin, M., Papangeli, I., Simonson, B., Akkad, A.-D., Hill, M. C., Arduini, A., Fleming, S. J., Melanson, M., Hayat, S., Kost-Alimova, M., et al. (2022) · Nature · doi:10.1038/s41586-022-04817-8 · Cited by 418
Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy
Rubinshtein, R., Glockner, J. F., Ommen, S. R., Araoz, P. A., Ackerman, M. J., Sorajja, P., Bos, J. M., Tajik, A. J., Valeti, U. S., Nishimura, R. A., et al. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.854026 · Cited by 418
Self-citation
Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity
Alfares, A. A., Kelly, M. A., McDermott, G., Funke, B. H., Lebo, M. S., Baxter, S. B., Shen, J., McLaughlin, H. M., Clark, E. H., Babb, L. J., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.205 · Cited by 412
Self-citation
Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy
Sherrid, M. V., Barac, I., McKenna, W. J., Elliott, P. M., Dickie, S., Chojnowska, L., Casey, S., & Maron, B. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.012 · Cited by 410
Shared Genetic Causes of Cardiac Hypertrophy in Children and Adults
Morita, H., Rehm, H. L., Menesses, A., McDonough, B. A., Roberts, A. E., Kucherlapati, R., Towbin, J. A., Seidman, J. G., & Seidman, C. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa075463 · Cited by 404
Sudden Death in Young Adults
Eckart, R. E., Shry, E. A., BURKE, A. P., McNear, J., Appel, D. A., Castillo-Rojas, L. M., Avedissian, L. S., Pearse, L. A., Potter, R. N., Tremaine, L. A., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.049 · Cited by 402
Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy
Maron, B. J., Olivotto, I., Bellone, P., Conte, M. R., Cecchi, F., Flygenring, B., Casey, S. A., Gohman, T. E., Bongioanni, S., & Spirito, P. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01727-2 · Cited by 396
Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy.
Bonow, R. O., Rosing, D. R., Bacharach, S. L., Green, M. V., Kent, K. M., Lipson, L. C., Maron, B. J., Leon, M. B., & Epstein, S. E. (1981) · Circulation · doi:10.1161/01.cir.64.4.787 · Cited by 393
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
Desai, M. Y., OWENS, A. T., Geske, J. B., Wolski, K., Naidu, S. S., Smedira, N. G., Cremer, P. C., Schaff, H. V., McErlean, E. S., Sewell, C., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.04.048 · Cited by 393
Self-citation
Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling
Ingles, J., Doolan, A., Chiu, C., Seidman, J. G., Seidman, C. E., & Semsarian, C. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.033886 · Cited by 385
Self-citation
Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events
BOTTO, G. L., PADELETTI, L., SANTINI, M., CAPUCCI, A., GULIZIA, M., ZOLEZZI, F., FAVALE, S., MOLON, G., RICCI, R., BIFFI, M., et al. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01320.x · Cited by 380
Dual-Chamber Pacing for Hypertrophic Cardiomyopathy: A Randomized, Double-Blind, Crossover Trial
Nishimura, R. A., Trusty, J. M., Hayes, D. L., Ilstrup, D. M., Larson, D. R., Hayes, S. N., Allison, T. G., & Tajik, A. J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00473-1 · Cited by 376
Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen’s Inherited Cardiomyopathy Expert Panel
Kelly, M., Caleshu, C. A., Morales, A., Buchan, J. G., Wolf, Z. T., Harrison, S. M., Cook, S. A., Dillon, M. W., Garcia, J., Haverfield, E. V., et al. (2018) · Genetics in Medicine · doi:10.1038/gim.2017.218 · Cited by 373
Self-citation
Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm
Rowin, E. J., Maron, B. J., Haas, T. S., Garberich, R., Wang, W., Link, M. S., & Maron, M. S. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.063 · Cited by 369
Syncope and risk of sudden death in hypertrophic cardiomyopathy
Spirito, P., Autore, C., Rapezzi, C., Bernabò, P., Badagliacca, R., Maron, M. S., Bongioanni, S., Coccolo, F., Estes, N. A. M., Barillà, C. S., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.798314 · Cited by 365
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy
Ho, C. Y., Mealiffe, M. E., Bach, R. G., Bhattacharya, M., Choudhury, L., Edelberg, J. M., Hegde, S. M., Jacoby, D. L., Lakdawala, N. K., Lester, S. J., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.064 · Cited by 359
Self-citation
Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review
Guttmann, O. P., Rahman, M. S., O’Mahony, C., Anastasakis, A., & Elliot, P. M. (2013) · Heart · doi:10.1136/heartjnl-2013-304276 · Cited by 357
Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity
Harper, A. R., Goel, A., Grace, C., Thomson, K. L., Petersen, S. E., Xu, X., Waring, A., Ormondroyd, E., Kramer, C. M., Ho, C. Y., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00764-0 · Cited by 353
Self-citation
Patterns of Disease Progression in Hypertrophic Cardiomyopathy
Olivotto, I., Cecchi, F., Poggesi, C., & Yacoub, M. H. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.967026 · Cited by 352
American Society of Echocardiography Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy
Nagueh, S. F., Bierig, S. M., Budoff, M. J., Desai, M. Y., Dilsizian, V., Eidem, B. W., Goldstein, S. A., Hung, J., Maron, M. S., Ommen, S. R., et al. (2011) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2011.03.006 · Cited by 346
Self-citation
Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy
Faber, L., Seggewiß, H., & Gleichmann, U. (1998) · Circulation · doi:10.1161/01.cir.98.22.2415 · Cited by 346
Clinical Outcome and Phenotypic Expression in LAMP2 Cardiomyopathy
Maron, B. J. (2009) · JAMA · doi:10.1001/jama.2009.371 · Cited by 343
Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy
Burke, M. A., Cook, S. A., Seidman, J. G., & Seidman, C. E. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.08.079 · Cited by 336
Self-citation
Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy
Woo, A., Williams, W. G., Choi, R., Wigle, E. D., Rozenblyum, E., Fedwick, K., Siu, S. C., Ralph-Edwards, A. C., & Rakowski, H. (2005) · Circulation · doi:10.1161/01.cir.0000162460.36735.71 · Cited by 334
Prospective Prognostic Assessment of Blood Pressure Response During Exercise in Patients With Hypertrophic Cardiomyopathy
Sadoul, N., Prasad, K., Elliot, P. M., Bannerjee, S., Frenneaux, M. P., & McKenna, W. J. (1997) · Circulation · doi:10.1161/01.cir.96.9.2987 · Cited by 331
Evaluation of Left Ventricular Filling Pressures by Doppler Echocardiography in Patients With Hypertrophic Cardiomyopathy
Geske, J. B., Sorajja, P., Nishimura, R. A., & Ommen, S. R. (2007) · Circulation · doi:10.1161/circulationaha.107.698985 · Cited by 328
Self-citation
Heart failure management using implantable devices for ventricular resynchronization: Comparison of medical therapy, pacing, and defibrillation in chronic heart failure (COMPANION) trial
Bristow, M. R., Feldman, A. M., & Saxon, L. A. (2000) · Journal of Cardiac Failure · doi:10.1054/jcaf.2000.9501 · Cited by 328
Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy
Maron, M. S., Rowin, E. J., Wessler, B. S., Mooney, P., Fatima, A., Patel, P. P., Koethe, B. C., Romashko, M. D., Link, M. S., & Maron, B. J. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1391 · Cited by 323
Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A two-dimensional echocardiographic study
Shapiro, L. M., & McKenna, W. J. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80269-1 · Cited by 322
Hypertrophic Cardiomyopathy
Geske, J. B., Ommen, S. R., & Gersh, B. J. (2018) · JACC Heart Failure · doi:10.1016/j.jchf.2018.02.010 · Cited by 319
Self-citation
Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies
Maron, B. J., Rowin, E. J., Casey, S. A., Link, M. S., Lesser, J. R., Chan, R. H. M., Garberich, R. F., Udelson, J. E., & Maron, M. S. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.061 · Cited by 317
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and Evidence From New Hypertension Trials
Jones, D. W., & Hall, J. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000110061.06674.ca · Cited by 309
Mavacamten Treatment for Obstructive Hypertrophic Cardiomyopathy
Heitner, S. B., Jacoby, D. L., Lester, S. J., OWENS, A. T., Wang, A., Zhang, D., Lambing, J. L., Lee, J., Semigran, M. J., & Sehnert, A. J. (2019) · Annals of Internal Medicine · doi:10.7326/m18-3016 · Cited by 307
Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy
Kim, L. K., Swaminathan, R. V., Looser, P. M., Minutello, R. M., Wong, S. C., Bergman, G. W., Naidu, S. S., Gade, C. L., Charitakis, K., Singh, H. S., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.0252 · Cited by 304
Self-citation
Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
Sorajja, P., Valeti, U. S., Nishimura, R. A., Ommen, S. R., Rihal, C. S., Gersh, B. J., Hodge, D. O., Schaff, H. V., & Holmes, D. R. (2008) · Circulation · doi:10.1161/circulationaha.107.738740 · Cited by 303
Self-citation
Pacing in hypertrophic obstructive cardiomyopathy: A randomized crossover study
KAPPENBERGER, L. J., Linde, C. M., Daubert, C., McKenna, W. J., Meisel, E., Sadoul, N., Chojnowska, L., Guize, L., Gras, D., Jeanrenaud, X., et al. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015435 · Cited by 295
Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System
Halperin, J. L., Levine, G. N., Al‐Khatib, S. M., Birtcher, K. K., Bozkurt, B., Brindis, R. G., Cigarroa, J. E., Curtis, L. H., Fleisher, L. A., Gentile, F., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000312 · Cited by 295
Self-citation
Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
Sorajja, P., Ommen, S. R., Holmes, D. R., Dearani, J. A., Rihal, C. S., Gersh, B. J., Lennon, R. J., & Nishimura, R. A. (2012) · Circulation · doi:10.1161/circulationaha.111.076257 · Cited by 293
Self-citation
Sudden cardiac death in the young: the molecular autopsy and a practical approach to surviving relatives
Semsarian, C., Ingles, J., & Wilde, A. A. M. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv063 · Cited by 292
Self-citation
Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy
Maron, B. J., Spirito, P., Ackerman, M. J., Casey, S. A., Semsarian, C., Estes, N. A. M., Shannon, K. M., Ashley, E. A., Day, S. M., Pacileo, G., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.037 · Cited by 288
Self-citation
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect
Tadros, R., Francis, C., Xu, X. Y., Vermeer, A. M. C., Harper, A. R., Huurman, R., Bisabu, K. K., Walsh, R., Hoorntje, E. T., Rijdt, W. P. T., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00762-2 · Cited by 288
Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Results of a Prospective, Multinational Registry
Lampert, R., Olshansky, B., Heidbuchel, H., Lawless, C., Saarel, E., Ackerman, M., Calkins, H., Estes, N. A. M., Link, M. S., Maron, B. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000447 · Cited by 286
Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis
Mahajan, R., Perera, T., Elliott, A. D., Twomey, D. J., Kumar, S. K., Munwar, D. A., Khokhar, K. B., Thiyagarajah, A., Middeldorp, M. E., Nalliah, C. J., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx731 · Cited by 284
Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy.
Frenneaux, M. P., Counihan, P. J., Caforio, A. L. P., Chikamori, T., & McKenna, W. J. (1990) · Circulation · doi:10.1161/01.cir.82.6.1995 · Cited by 282
Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population
Siontis, K. C., Geske, J. B., Ong, K., Nishimura, R. A., Ommen, S. R., & Gersh, B. J. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001002 · Cited by 276
Self-citation
Updated Meta-Analysis of Septal Alcohol Ablation Versus Myectomy for Hypertrophic Cardiomyopathy
Agarwal, S., Tuzcu, E. M., Desai, M. Y., Smedira, N. G., Lever, H. M., Lytle, B. W., & Kapadia, S. R. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.047 · Cited by 276
The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy
Sherrid, M. V., Balaram, S. K., Kim, B., Axel, L., & Swistel, D. G. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.071 · Cited by 276
Tissue Doppler Imaging Predicts the Development of Hypertrophic Cardiomyopathy in Subjects With Subclinical Disease
Nagueh, S. F., McFalls, J., Meyer, D., Hill, R., Zoghbi, W. A., Tam, J. W., Quiñones, M. A., Roberts, R., & Marian, A. J. (2003) · Circulation · doi:10.1161/01.cir.0000084500.72232.8d · Cited by 275
Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy
Adabag, A. S., Casey, S. A., Kuskowski, M. A., Zenovich, A. G., & Maron, B. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.043 · Cited by 273
Current Effectiveness and Risks of Isolated Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy
Smedira, N. G., Lytle, B. W., Lever, H. M., Rajeswaran, J., Krishnaswamy, G., Kaple, R., Dolney, D., & Blackstone, E. H. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.07.063 · Cited by 271
Myocardial Bridging in Children with Hypertrophic Cardiomyopathy — A Risk Factor for Sudden Death
Yetman, A. T., McCrindle, B. W., MacDonald, C., Freedom, R. M., & Gow, R. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391704 · Cited by 265
The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms
Autore, C., Bernabò, P., Barillà, C. S., Bruzzi, P., & Spirito, P. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.067 · Cited by 263
Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy
Rowin, E. J., Hausvater, A., Link, M. S., Abt, P., Gionfriddo, W., Wang, W., Rastegar, H., Estes, N. A. M., Maron, M. S., & Maron, B. J. (2017) · Circulation · doi:10.1161/circulationaha.117.029267 · Cited by 262
Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
Elliot, P. M., Sharma, S., Varnava, A. M., Poloniecki, J. D., Rowland, E., & McKenna, W. J. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00056-x · Cited by 257
Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy
Shah, J., Esteban, M. T. T., Thaman, R., Sharma, R., Mist, B., Pantazis, A. A., Ward, D., Kohli, S. K., Page, S. P., Demetrescu, C. D., et al. (2007) · Heart · doi:10.1136/hrt.2007.126003 · Cited by 257
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management
Task Force Chairs, Daubert, J., Saxon, L. A., Adamson, P. B., Auricchio, A., Berger, R. D., Beshai, J. F., Breithard, O., Brignole, M., Cleland, J. G. F., et al. (2012) · EP Europace · doi:10.1093/europace/eus222 · Cited by 257
Dual-Chamber Versus Single-Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis
Friedman, P. A., McClelland, R. L., Bamlet, W. R., Acosta, H., Kessler, D. J., Munger, T. M., Kavesh, N. G., Wood, M., Daoud, E. G., Massumi, A., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.594531 · Cited by 255
Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)
Norrish, G., Ding, T., Field, E., Ziółkowska, L., Olivotto, I., Limongelli, G., Anastasakis, A., Weintraub, R. G., Biagini, E., Ragni, L., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.2861 · Cited by 255
Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy
Olivotto, I., Maron, B. J., Montereggi, A., Mazzuoli, F., Dolara, A., & Cecchi, F. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00094-7 · Cited by 254
Device-detected subclinical atrial tachyarrhythmias: definition, implications and management—an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)
Görenek, B., Bax, J. J., Boriani, G., Chen, S., Dagres, N., Glotzer, T. V., Healey, J. S., Israel, C. W., Kudaiberdieva, G., Levin, L., et al. (2017) · EP Europace · doi:10.1093/europace/eux163 · Cited by 249
How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality: Shaped by 50 Years of Clinical Research and Practice
Maron, B. J., Rowin, E. J., Casey, S. A., & Maron, M. S. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2015.0354 · Cited by 246
Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.
Rosing, D. R., Kent, K. M., Maron, B. J., & Epstein, S. E. (1979) · Circulation · doi:10.1161/01.cir.60.6.1208 · Cited by 244
Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy: A Randomized Clinical Trial
Saberi, S., Wheeler, M., Bragg-Gresham, J., Hornsby, W., Agarwal, P. P., Attili, A., Concannon, M., Dries, A. M., Shmargad, Y., Salisbury, H., et al. (2017) · JAMA · doi:10.1001/jama.2017.2503 · Cited by 241
Self-citation
Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function
Mentias, A. G., Raeisi‐Giglou, P., Smedira, N. G., Feng, K., Sato, K., Wazni, O. M., Kanj, M., Flamm, S. D., Thamilarasan, M., Popović, Z., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.060 · Cited by 240
Atrial fibrillation in hypertrophie cardiomyopathy: A longitudinal study
Robinson, K., Frenneaux, M. P., Stockins, B., Karatasakis, G., Poloniecki, J. D., & Mckenna, W. J. (1990) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80014-2 · Cited by 237
Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: Clarification of pathophysiology and importance in intraoperative decision making
Grigg, L., Wigle, E. D., Williams, W. G., Daniel, L. B., & Rakowski, H. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90135-a · Cited by 234
Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy
Melacini, P., Basso, C., Angelini, A., Calore, C., Bobbo, F., Tokajuk, B., Bellini, N., Smaniotto, G., Zucchetto, M., Iliceto, S., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq136 · Cited by 234
Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae
Minakata, K., Dearani, J. A., Nishimura, R. A., Maron, B. J., & Danielson, G. K. (2004) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2003.09.040 · Cited by 230
Self-citation
Characterization of Left Ventricular Diastolic Function by Tissue Doppler Imaging and Clinical Status in Children With Hypertrophic Cardiomyopathy
McMahon, C. J., Nagueh, S. F., Pignatelli, R. H., Denfield, S. W., Dreyer, W. J., Price, J. F., Clunie, S. K., Bezold, L. I., Hays, A. L., Towbin, J. A., et al. (2004) · Circulation · doi:10.1161/01.cir.0000124723.16433.31 · Cited by 228
Dynamic intraventricular obstruction during dobutamine stress echocardiography. A new observation.
Pellikka, P. A., Oh, J. K., Bailey, K. R., Nichols, B. A., Monahan, K. H., & Tajik, A. J. (1992) · Circulation · doi:10.1161/01.cir.86.5.1429 · Cited by 228
Outcomes of Restrictive Cardiomyopathy in Childhood and the Influence of Phenotype
Webber, S. A., Lipshultz, S. E., Sleeper, L. A., Lü, M., Wilkinson, J. D., Addonizio, L. J., Canter, C. E., Colan, S. D., Everitt, M. D., Jefferies, J. L., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.104638 · Cited by 227
A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy
Miron, A., Lafrenière‐Roula, M., Fan, C. S., Armstrong, K. R., Dragulescu, A., Papaz, T., Manlhiot, C., Kaufman, B. D., Butts, R. J., Gardin, L., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.047235 · Cited by 225
Self-citation
Dilated-Hypokinetic Evolution of Hypertrophic Cardiomyopathy
Biagini, E., Coccolo, F., Ferlito, M., Perugini, E., Rocchi, G., Reggiani, M. L. B., Lofiego, C., Boriani, G., Prandstraller, D., Picchio, F. M., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.062 · Cited by 224
Risk Stratification and Outcome of Patients With Hypertrophic Cardiomyopathy ≥60 Years of Age
Maron, B. J., Rowin, E. J., Casey, S. A., Haas, T. S., Chan, R. H. M., Udelson, J. E., Garberich, R. F., Lesser, J. R., Appelbaum, E., Manning, W. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.136085 · Cited by 224
Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG)
Deignan, J. L., Chung, W. K., Kearney, H. M., Monaghan, K. G., Rehder, C. W., & Chao, E. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0478-1 · Cited by 224
AHA/ACC/HHS Strategies to Enhance Application of Clinical Practice Guidelines in Patients With Cardiovascular Disease and Comorbid Conditions
Arnett, D. K., Goodman, R. A., Halperin, J. L., Anderson, J. L., Parekh, A. K., & Zoghbi, W. A. (2014) · Circulation · doi:10.1161/cir.0000000000000128 · Cited by 223
Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry
Marstrand, P., Han, L., Day, S. M., Olivotto, I., Ashley, E. A., Michels, M., Pereira, A. C., Wittekind, S. G., Helms, A., Saberi, S., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044366 · Cited by 219
Self-citation
Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs∗
D, E. B. M., & Ebert, P. A. (1962) · The American Journal of Cardiology · doi:10.1016/0002-9149(62)90373-9 · Cited by 217
A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy
Liebregts, M., Vriesendorp, P. A., Mahmoodi, B. K., Schinkel, A. F. L., Michels, M., & ten Berg, J. M. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2015.06.011 · Cited by 216
Progress With Genetic Cardiomyopathies
Hershberger, R. E., Cowan, J. R., Morales, A., & Siegfried, J. D. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.817346 · Cited by 216
Prevalence of Anderson–Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson–Fabry Disease Survey
Elliot, P. M., Baker, R. J., Pasquale, F., Quarta, G., Ebrahim, H. Y., Mehta, A. B., & Hughes, D. A. (2011) · Heart · doi:10.1136/heartjnl-2011-300364 · Cited by 207
Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy
Patel, P., Dhillon, A. S., Popović, Z., Smedira, N. G., Rizzo, J., Thamilarasan, M., Agler, D. A., Lytle, B. W., Lever, H. M., & Desai, M. Y. (2015) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.003132 · Cited by 207
Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry
Lipshultz, S. E., Orav, E. J., Wilkinson, J. D., Towbin, J. A., Messere, J. E., Lowe, A. M., Sleeper, L. A., Cox, G. F., Hsu, D. T., Canter, C. E., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61685-2 · Cited by 207
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
Maron, M. S., Masri, A., Choudhury, L., Olivotto, I., Saberi, S., Wang, A., García‐Pavía, P., Lakdawala, N. K., Nagueh, S. F., Rader, F., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.10.020 · Cited by 207
Self-citation
Amelioration of Angina Pectoris in Idiopathic Hypertrophic Subaortic Stenosis with Beta-Adrenergic Blockade
Cohen, L. S., & Braunwald, E. (1967) · Circulation · doi:10.1161/01.cir.35.5.847 · Cited by 204
Myocardial Stiffness Evaluation Using Noninvasive Shear Wave Imaging in Healthy and Hypertrophic Cardiomyopathic Adults
Villemain, O., Correia, M., Mousseaux, É., Baranger, J., Zarka, S., Podetti, I., Soulat, G., Damy, T., Hagège, A. A., Tanter, M., et al. (2018) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.02.002 · Cited by 204
Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy
McLeod, C. J., Ommen, S. R., Ackerman, M. J., Weivoda, P. L., Shen, W.-K., Dearani, J. A., Schaff, H. V., Tajik, A. J., & Gersh, B. J. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm117 · Cited by 203
Self-citation
International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)
O’Mahony, C., Jichi, F., Ommen, S. R., Christiaans, I., Arbustini, E., Garcia-Pavia, P., Cecchi, F., Olivotto, I., Kitaoka, H., Gotsman, I., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.030437 · Cited by 201
Self-citation
Risk associated with pregnancy in hypertrophic cardiomyopathy
Autore, C., Conte, M. R., Piccininno, M., Bernabò, P., Bonfiglio, G., Bruzzi, P., & Spirito, P. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02495-6 · Cited by 199
Transaortic Chordal Cutting
Ferrazzi, P., Spirito, P., Iacovoni, A., Calabrese, A., Migliorati, K., Simon, C., Pentiricci, S., Poggio, D., Grillo, M., Amigoni, P., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.069 · Cited by 198
Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease
Sorajja, P., Ommen, S. R., Nishimura, R. A., Gersh, B. J., Berger, P. B., & Tajik, A. J. (2003) · Circulation · doi:10.1161/01.cir.0000097110.55312.bf · Cited by 198
Self-citation
Long-term Clinical and Echocardiographic Follow-up After Surgical Correction of Hypertrophic Obstructive Cardiomyopathy With Extended Myectomy and Reconstruction of the Subvalvular Mitral Apparatus
Schöndube, F. A., Klues, H. G., Reith, S., Flachskampf, F. A., Hanrath, P., & Messmer, B. J. (1995) · Circulation · doi:10.1161/01.cir.92.9.122 · Cited by 196
Clinical Features and Outcomes of Childhood Hypertrophic Cardiomyopathy
Nugent, A. W., Daubeney, P. E. F., Chondros, P., Carlin, J. B., Colan, S. D., Cheung, M. M. H., Davis, A. M., Chow, C. W., & Weintraub, R. G. (2005) · Circulation · doi:10.1161/circulationaha.104.530303 · Cited by 196
Predictors of Long-Term Outcomes in Symptomatic Hypertrophic Obstructive Cardiomyopathy Patients Undergoing Surgical Relief of Left Ventricular Outflow Tract Obstruction
Desai, M. Y., Bhonsale, A., Smedira, N. G., Naji, P., Thamilarasan, M., Lytle, B. W., & Lever, H. M. (2013) · Circulation · doi:10.1161/circulationaha.112.000849 · Cited by 193
Sudden Cardiac Arrest during Participation in Competitive Sports
Landry, C. H., Allan, K. S., Connelly, K. A., Cunningham, K., Morrison, L. J., & Dorian, P. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615710 · Cited by 192
Left Ventricular Assist Device Therapy in Patients With Restrictive and Hypertrophic Cardiomyopathy
Topilsky, Y., Pereira, N. L., Shah, D. K., Boilson, B. A., Schirger, J. A., Kushwaha, S. S., Joyce, L. D., & Park, S. J. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.959288 · Cited by 192
Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy
Bagnall, R. D., Ingles, J., Dinger, M. E., Cowley, M. J., Ross, S. B., Minoche, A. E., Lal, S., Turner, C., Colley, A., Rajagopalan, S., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.078 · Cited by 192
Self-citation
Mitral Regurgitation in Patients With Hypertrophic Obstructive Cardiomyopathy
Hong, J. H., Schaff, H. V., Nishimura, R. A., Abel, M. D., Dearani, J. A., Li, Z., & Ommen, S. R. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.07.735 · Cited by 191
Self-citation
Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
Kwon, D. H., Setser, R. M., Thamilarasan, M., Popović, Z., Smedira, N. G., Schoenhagen, P., Garcia, M. J., Lever, H. M., & Desai, M. Y. (2007) · Heart · doi:10.1136/hrt.2007.118018 · Cited by 188
Pathogeneses of Sudden Cardiac Death in National Collegiate Athletic Association Athletes
Harmon, K. G., Drezner, J. A., Maleszewski, J. J., Lopez-Anderson, M., Owens, D., Prutkin, J. M., Asif, I. M., Klossner, D., & Ackerman, M. J. (2014) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.113.001376 · Cited by 184
Self-citation
Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis of randomized controlled trials
Santangeli, P., Muser, D., Maeda, S., Filtz, A., Zado, E. S., Frankel, D. S., Dixit, S., Epstein, A. E., Callans, D. J., & Marchlinski, F. E. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.03.004 · Cited by 184
Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy
Ismail, T. F., Jabbour, A., Gulati, A., Mallorie, A., Raza, S., Cowling, T. E., Das, B., Khwaja, J., Alpendurada, F., Wage, R., et al. (2014) · Heart · doi:10.1136/heartjnl-2013-305471 · Cited by 183
Low Operative Mortality Achieved With Surgical Septal Myectomy
Maron, B. J., Dearani, J. A., Ommen, S. R., Maron, M. S., Schaff, H. V., Nishimura, R. A., Ralph-Edwards, A., Rakowski, H., Sherrid, M. V., Swistel, D. G., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1333 · Cited by 183
Self-citation
Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction
Rowin, E. J., Maron, B. J., Carrick, R. T., Patel, P. P., Koethe, B. C., Wells, S. B., & Maron, M. S. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.045 · Cited by 183
Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence
Spoladore, R., Maron, M. S., D’Amato, R., Camici, P. G., & Olivotto, I. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs150 · Cited by 181
Mitral Valve Abnormalities in Hypertrophic Cardiomyopathy: Echocardiographic Features and Surgical Outcomes
Kaple, R., Murphy, R. T., DiPaola, L. M., Houghtaling, P. L., Lever, H. M., Lytle, B. W., Blackstone, E. H., & Smedira, N. G. (2008) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2008.01.061 · Cited by 180
Treatment of Obstructive Hypertrophic Cardiomyopathy Symptoms and Gradient Resistant to First-Line Therapy With β-Blockade or Verapamil
Sherrid, M. V., Shetty, A., Winson, G., Kim, B., Musat, D., Alviar, C. L., Homel, P., Balaram, S. K., & Swistel, D. G. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000122 · Cited by 178
Obesity and its Association to Phenotype and Clinical Course in Hypertrophic Cardiomyopathy
Olivotto, I., Maron, B. J., Tomberli, B., Appelbaum, E. A., Salton, C. J., Haas, T. S., Gibson, C. M., Nistri, S., Servettini, E., Chan, R. H. M., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.062 · Cited by 174
The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy
O’Mahony, C., Lambiase, P. D., Quarta, G., Cardona, M., Calcagnino, M. M., Tsovolas, K., Al-Shaikh, S., Rahman, S. M., Arnous, S., Jones, S., et al. (2011) · Heart · doi:10.1136/hrt.2010.217182 · Cited by 174
Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies
Maron, B. J., Rowin, E. J., Casey, S. A., Lesser, J. R., Garberich, R., McGriff, D. M., & Maron, M. S. (2015) · Circulation · doi:10.1161/circulationaha.115.017633 · Cited by 172
Long-Term Survival in Patients With Resting Obstructive Hypertrophic Cardiomyopathy
Ball, W., Ivanov, J., Rakowski, H., Wigle, E. D., Linghorne, M., Ralph-Edwards, A. C., Williams, W. G., Schwartz, L., Guttman, A., & Woo, A. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.040 · Cited by 170

Research works printed but not linked: 227

Committee on Standards for Systematic Reviews of Comparative Effectiveness Research Institute of Medicine (US). Finding What Works in Health Care: Standards for Systematic Reviews. National Academies Press; 2011.
Animal Studies-Standard-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/54.
Guidelines-Broad-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/75.
Guidelines-Standard-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/77.
RCT/ CCT-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/108.
SR/ MA/ HTA/ ITC-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022: Accessed September 14, 2022. https://searchfilters.cadth.ca/link/99.
10.1016/s0025-6196(11)64198-0 · DOI
10.1016/j.jacc.2014.05.003 · DOI · Paper page
10.1056/nejmra1710575 · DOI · Paper page
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1001/jamacardio.2015.0354 · DOI · Paper page
10.1056/nejmra1710575 · DOI · Paper page
10.1016/j.jacc.2015.01.019 · DOI
10.1016/j.jacc.2014.05.003 · DOI · Paper page
10.1016/j.jacc.2018.10.007 · DOI
10.1016/j.echo.2010.10.006 · DOI
10.1161/circulationaha.106.644682 · DOI
10.1016/j.amjcard.2017.08.047 · DOI
10.1093/ehjci/jew313 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1016/j.jacc.2013.02.079 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.01.071 · DOI
10.1016/j.jacc.2012.03.076 · DOI
10.1016/j.jacc.2010.11.002 · DOI
10.1016/j.echo.2011.03.006 · DOI
10.1161/circulationaha.107.698985 · DOI
10.1016/j.jcin.2011.02.014 · DOI
10.1016/j.amjcard.2007.09.111 · DOI
10.1161/01.cir.0000097110.55312.bf · DOI
10.1016/j.echo.2010.10.006 · DOI
10.1161/circulationaha.106.644682 · DOI
10.1016/j.amjcard.2017.08.047 · DOI
10.1093/ejechocard/jeq063 · DOI
10.1093/ehjci/jew313 · DOI
10.1136/hrt.2007.126003 · DOI
10.1056/nejmoa021332 · DOI · Paper page
10.1016/s0002-9149(99)80416-0 · DOI
10.1161/01.cir.0000162460.36735.71 · DOI
10.1016/j.jacc.2013.02.079 · DOI
10.1161/hcg.0000000000000054 · DOI
10.1093/eurheartj/ehq271 · DOI
10.1016/j.jacc.2012.02.068 · DOI
10.1161/circgen.117.001896 · DOI · Paper page
10.1161/circulationaha.114.013478 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1016/j.hrthm.2011.07.017 · DOI
10.1161/circulationaha.111.090514 · DOI
10.1161/circgenetics.116.001620 · DOI
10.1161/circulationaha.118.038846 · DOI
10.1016/j.jacc.2015.01.019 · DOI
10.1161/circulationaha.111.090514 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1161/circulationaha.118.037264 · DOI
10.1161/circulationaha.118.038846 · DOI
10.1016/j.jpeds.2017.03.033 · DOI
10.1093/eurheartj/ehr092 · DOI · Paper page
10.1148/radiol.2018180339 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1007/s10554-016-0858-4 · DOI
10.1016/j.amjcard.2016.11.010 · DOI
10.1016/j.amjcard.2010.01.367 · DOI
10.1016/j.jcmg.2016.02.031 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jacc.2018.05.060 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1016/j.echo.2011.03.002 · DOI
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1161/circulationaha.120.047235 · DOI
10.1111/cge.13157 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1093/europace/euz118 · DOI
10.1161/circulationaha.122.062699 · DOI
10.1161/circulationaha.120.047235 · DOI
10.1001/jamacardio.2019.2861 · DOI
10.1001/jamacardio.2018.0789 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1093/europace/euz118 · DOI
10.1177/2047487317702519 · DOI
10.1161/circheartfailure.113.000414 · DOI
10.1016/j.amjcard.2013.12.034 · DOI
10.1111/chd.12286 · DOI
10.1093/eurjpc/zwab181 · DOI
10.1016/j.jacc.2015.03.552 · DOI
10.1111/cge.13157 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/j.jjcc.2014.02.011 · DOI
10.1007/s10554-016-0858-4 · DOI
10.1016/j.amjcard.2016.11.010 · DOI
10.1016/j.amjcard.2010.01.367 · DOI
10.1016/j.jcmg.2016.02.031 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jacc.2018.05.060 · DOI
10.1001/jamacardio.2019.1391 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1016/j.jacc.2020.04.045 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1161/circulationaha.122.062699 · DOI
10.1016/s0735-1097(99)00056-x · DOI
10.1016/j.amjcard.2010.06.077 · DOI · Paper page
10.1056/nejm200006153422403 · DOI
10.1016/s0140-6736(00)04005-8 · DOI
10.1161/circulationaha.108.798314 · DOI · Paper page
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1017/s1047951105001824 · DOI
10.1038/nrcardio.2017.6 · DOI
10.1001/jamacardio.2019.1391 · DOI
10.1001/jama.298.4.405 · DOI
10.1016/j.ahj.2013.06.009 · DOI
10.1016/s0735-1097(99)00056-x · DOI
10.1161/circulationaha.108.798314 · DOI · Paper page
10.1016/j.amjcard.2010.06.077 · DOI · Paper page
10.1093/eurheartj/ehq308 · DOI
10.1056/nejm200006153422403 · DOI
10.1016/j.jacc.2004.12.067 · DOI
10.1016/s0140-6736(00)04005-8 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/j.jjcc.2014.02.011 · DOI
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1093/eurheartj/eht439 · DOI · Paper page
10.1016/j.jacc.2020.04.045 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1016/j.jacc.2013.01.037 · DOI
10.1177/2047487317702519 · DOI
10.1007/s00246-011-9967-y · DOI
10.1016/s0735-1097(98)00493-8 · DOI
10.1016/j.jacc.2015.03.552 · DOI
10.1007/s00246-013-0676-6 · DOI
10.1161/circulationaha.115.017633 · DOI
10.1161/circulationaha.120.047235 · DOI
10.1093/eurjpc/zwab181 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jcmg.2016.02.031 · DOI
10.1016/j.jacc.2018.05.060 · DOI
10.1016/j.amjcard.2013.12.034 · DOI
10.1161/circulationaha.112.136085 · DOI · Paper page
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1016/j.amjcard.2020.04.042 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1016/j.jacc.2009.03.051 · DOI
10.1016/j.jacc.2013.01.037 · DOI
10.1161/cir.0000000000001063 · DOI · Paper page
10.1161/cir.0000000000000628 · DOI · Paper page
10.1161/circulationaha.106.644682 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1016/j.jacc.2015.06.1333 · DOI · Paper page
10.1161/circulationaha.106.644682 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1016/j.amjcard.2013.01.340 · DOI
10.1016/j.jcmg.2013.08.010 · DOI
10.1001/jamacardio.2016.0252 · DOI
10.1016/j.jtcvs.2018.11.148 · DOI
10.1016/j.mayocp.2018.07.022 · DOI
10.1016/j.jacc.2016.07.735 · DOI · Paper page
10.1016/j.echo.2018.10.011 · DOI
10.1136/hrt.2007.118018 · DOI
10.1161/circulationaha.117.029267 · DOI · Paper page
10.1161/01.cir.0000162460.36735.71 · DOI
Liebregts, M, Vriesendorp, PA, Mahmoodi, BK, et al. A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol HF. 2015;3:896–905.
10.1536/ihj.27.701 · DOI
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1161/01.cir.0000097110.55312.bf · DOI
10.1161/cir.0000000000001063 · DOI · Paper page
10.1161/circulationaha.105.583500 · DOI
10.1093/eurheartj/ehq136 · DOI
10.1161/circheartfailure.114.002248 · DOI · Paper page
10.1253/circj.cj-16-0432 · DOI
10.1016/j.amjcard.2017.12.044 · DOI
10.1016/s0140-6736(20)31792-x · DOI · Paper page
10.1016/j.jacc.2020.04.045 · DOI
10.1016/j.ejheart.2008.03.006 · DOI
Gu, M, Jin, H, Hua, W, et al. Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy. J Geriatr Cardiol. 2017;14:238–244.
10.1016/j.jacc.2017.11.040 · DOI
10.1093/europace/euw327 · DOI
Rowin, EJ, Mohanty, S, Madias, C, et al. Benefit of cardiac resynchronization therapy in end-stage nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol EP. 2019;5:131–133.
10.1136/heartjnl-2013-305471 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1161/circheartfailure.114.001843 · DOI · Paper page
10.1016/s2213-8587(14)70241-4 · DOI
10.1016/j.amjcard.2016.08.092 · DOI
10.1111/jce.12982 · DOI
10.1161/circulationaha.117.029267 · DOI · Paper page
10.1016/j.jacc.2005.01.012 · DOI · Paper page
10.1161/jaha.116.005152 · DOI
10.1016/j.amjcard.2003.10.025 · DOI
10.1016/j.amjcard.2017.12.044 · DOI
10.1161/circheartfailure.114.001435 · DOI
10.1161/circep.110.957290 · DOI

200 of 227 shown

Sorted by citations

JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0002 · Cited by 275
2024 HRS expert consensus statement on arrhythmias in the athlete: Evaluation, treatment, and return to play
Lampert, R., Chung, E. H., Ackerman, M. J., Arroyo, A. R., Darden, D., Deo, R., Dolan, J., Etheridge, S. P., Gray, B. R., Harmon, K. G., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.05.018 · Cited by 167
Self-citation
HF STATS 2025: Heart Failure Epidemiology and Outcomes Statistics An Updated 2025 Report from the Heart Failure Society of America
Fonarow, G. C., Ahmad, F. S., Ahmad, T. A., Albert, N. M., Alexander, K. M., Baker, W. L., Bozkurt, B., Breathett, K. K., Carter, S. J., Cheng, R. K.-H., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.07.007 · Cited by 103
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Ndumele, C. E., Rodríguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M. S., Bangalore, S., Bozkurt, B., Breathett, K. K., Clarke, S. L., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001453 · Cited by 101
Self-citation
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome
Ndumele, C. E., Rodriguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M., Bangalore, S., Bozkurt, B., Breathett, K., Clarke, S. L., et al. (2026) · JACC · doi:10.1016/j.jacc.2026.03.056 · Cited by 90
Self-citation

See all 807

Authors: Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., Joglar, J. A., Khan, S. S., Kim, J. J., Kittleson, M. M., Krittanawong, C., Martinez, M. W., Mital, S., Naidu, S. S., Saberi, S., Semsarian, C., Times, S., & Waldman, C. B.
Affiliations: American Medical Society for Sports Medicine (US)
HRS representative.
Lay stakeholder representative.
AHA/ACC Joint Committee on Clinical Practice Guidelines liaison.
American Hospital Association (US)
PACES representative.
Joint ACC/AHA staff representative.
ORCID: Ommen, Steve R.
Ho, Carolyn Y.
Asif, Irfan M.
Balaji, Seshadri
Burke, Michael A.
Day, Sharlene M.
Dearani, Joseph A.
Ferrari, Victor A.
Joglar, José A.
Khan, Sadiya S.
Kim, Jeffrey J.
Kittleson, Michelle M.
Krittanawong, Chayakrit
Martinez, Matthew W.
Mital, Seema
Naidu, Srihari S.
Saberi, Sara
Semsarian, Christopher
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2024-06-04
Volume: 149
Issue: 23
Pages: e1239-e1311
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/cir.0000000000001250
OpenAlex: W4396750647
Cited by: 807
References: 514
Citations by year: 2026: 353 · 2025: 372 · 2024: 82
FWCI: 226.55
Type: journal article
Language: en
Update notices: correction (2024-08-19)
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Keywords: hypertrophic cardiomyopathy, disease management, inherited heart disease, diagnosis, treatment guidelines, American Heart Association, American College of Cardiology, American Society of Echocardiography
MeSH terms: American Heart Association, Cardiology, Cardiomyopathy, Hypertrophic, Humans, United States, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks